Vol 47, No 4 (2013)

open access

Page views 424
Article views/downloads 828
Get Citation

Connect on Social Media

Connect on Social Media

Incidence of mutations in the PARK2, PINK1, PARK7 genes in Polish early-onset Parkinson disease patients

Dariusz Koziorowski1, Dorota Hoffman-Zacharska23, Jarosław Sławek41, Zygmunt Jamrozik1, Piotr Janik1, Anna Potulska-Chromik1, Anna Roszmann41, Renata Tataj2, Jerzy Bal2, Andrzej Friedman1
DOI: 10.5114/ninp.2013.36756
Neurol Neurochir Pol 2013;47(4):319-324.


Background and purpose

Parkinson disease (PD) is a complex disease, comprising genetic and environmental factors. Despite the vast majority of sporadic cases, three genes, i.e. PARK2, PINK1 and PARK7 (DJ-1), have been identified as responsible for the autosomal recessive form of early-onset Parkinson disease (EO-PD). Identified changes of these genes are homozygous or compound heterozygous mutations. The frequency of PARK2, PINK1 and PARK7 mutations is still under debate, as is the significance and pathogenicity of the single heterozygous mutations/variants, which are also detected among PD patients. The aim of the study was to analyze the incidence of autosomal recessive genes PARK2, PINK1, PARK7 mutations in Polish EO-PD patients.

Material and methods

The analysis of the PARK2, PINK1 and PARK7 genes was performed in a group of 150 Polish EO-PD patients (age of onset < 45 years). Mutation analysis was based on sequencing and gene dosage abnormality identification.


Mutations were identified only in the PARK2 and PINK1 genes with the frequency of 4.7% and 2.7% of subjects, respectively. In PARK2, point mutations and exons' rearrangements, and in PINK1 only missense mutations were detected. In both genes mutations were found as compound heterozygous/homozygous and single heterozygous. EO-PD patients’ genotype-phenotype correlation revealed similarities of clinical features in mutation carriers and non-carriers.


The frequency of the PARK2, PINK1, PARK7 mutations among Polish EO-PD patients seems to be low. The role of single heterozygous mutations remains a matter of debate and needs further investigations.

Article available in PDF format

View PDF Download PDF file

Neurologia i Neurochirurgia Polska